The comparison of CD19+ B cells in acutely infected P. vivax patients from the same population during the follow-up to their recovery showed a greatly expansion of CD19+ B cells at 3 months recovery from infection (P = 0.0005, Fig. 4b). This evidence concerns the gene CD19 and infection.